Furthermore, the therapeutic effect of PTX and EVER administered in Dual-NPs was evaluated in mice bearing MDA-MB-231-H2N BC tumors which co-express HER2 and EGFR (HER2mod/EGFRmod). Here, ERBB2 is linked to breast cancer.